Phase II dose of cancer vaccine IMU-131 identified in HER2/neu-overexpressing stomach cancer trial April 16, 2019
Design of EBNA1-specific inhibitors suppressing Epstein-Barr virus-driven tumor growth April 16, 2019
RSS